Role of NLRC5 in the Activation of Hepatic Stellate Cells Induced by TGF-β1 and Reversal of Hepatic Fibrosis
Department of Interventional Therapy,Huamei Hospital,University of Chinese Academy of Sciences,Ningbo 315010,China
*Corresponding author:ZHANG Yan,Associate chief physician;E-mail:fanxiaoxiangdr@163.com
ZHANG Yan*,FAN Xiaoxiang,ZHANG Meiwu, et al. Role of NLRC5 in the Activation of Hepatic Stellate Cells Induced by TGF-β1 and Reversal of Hepatic Fibrosis[J]. Chinese General Practice, 2020, 23(24): 3051-3059. DOI: 10.12114/j.issn.1007-9572.2020.00.351.
张燕*,范晓翔,章美武等. LRC5调节转化生长因子-β1诱导的肝星状细胞活化及逆转对肝纤维化的影响[J]. 中国全科医学, 2020, 23(24): 3051-3059. DOI: 10.12114/j.issn.1007-9572.2020.00.351.
[1]邱冰峰,徐骐,徐汤舟,等.拉米夫定对乙型肝炎肝硬化患者肝纤维化状态与血小板参数的影响研究[J].中华医院感染学杂志,2016,26(8):1700-1702.DOI:10.11816/cn.ni.2016-153154.
QIU B F,XU Q,XU T Z,et al.Influence of lamivudine for fibrosis status and platelet parameters of patients with hepatitis B cirrhosis[J].Chin J Nosocomiol,2016,26(8) :1700-1702.DOI:10.11816/cn.ni.2016-153154.
[2]刘怀鄂,游晶,洪敏,等.辅助性T淋巴细胞17/调节性 T 淋巴细胞平衡在乙型肝炎病毒感染相关肝纤维化进展过程中的作用研究[J].中国全科医学,2016,19(18):2126-2129.DOI:10.3969/j.issn.1007-9572.2016.18.004.
LIU H E,YOU J,HONG M,et al.Study on the role of the balance Th17/treg in the development of hepatitis B virus - related liver fibrosis[J].Chinese General Practice,2016,19(18):2126-2129.DOI:10.3969/j.issn.1007-9572.2016.18.004.
[3]劳远翔,贺福初,姜颖.肝星状细胞的去活化机制与抗肝纤维化治疗[J].中华肝脏病杂志,2015,23(1):77-80.DOI:10.3760/cma.j.issn.1007-3418.2015.01.019.
LAO Y X,HE F C,JIANG Y.Deactivation mechanisms of hepatic stellate cells and their implications for anti-hepatic fibrosis therapy[J].Chin J Hepatol,2015,23(1):77-80.DOI:10.3760/cma.j.issn.1007-3418.2015.01.019.
[4]夏家露,严醒,刘亚如,等.SOCS3对四氯化碳诱导的小鼠肝纤维化进展和逆转的影响及机制研究[J].中国药理学通报,2017,33(9):1215-1221.DOI:10.3969/j.issn.1001-1978.2017.09.008.
XIA J L,YAN X,LIU Y R,et al.Effect of SOCS3 on progress of liver fibrosis and reversein mice induced by carbon tetrachloride and its mechanism[J].Chinese Pharmacological Bulletin,2017,33(9):1215-1221.DOI:10.3969/j.issn.1001-1978.2017.09.008.
[5]DOLASIA K,BISHT M K,PRADHAN G,et al.TLRs/NLRs:Shaping the landscape of host immunity[J].Int Rev Immunol,2018,37(1):3-19.DOI:10.1080/08830185.2017.1397656.
[6]CHANG G B,LIU X P,MA T,et al.A mutation in the NLRC5 promoter limits NF-κB signaling after Salmonella Enteritidis infection in the spleen of young chickens[J].Gene,2015,568(2):117-123.DOI:10.1016/j.gene.2015.05.023.
[7]LI L,XU T,HUANG C,et al.NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway[J].Inflammation,2014,37(3):835-847.DOI:10.1007/s10753-013-9804-y.
[8]CHEN Z,DING T,MA C G.Dexmedetomidine(DEX) protects against hepatic ischemia/reperfusion(I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice[J].Biochem Biophys Res Commun,2017,493(2):1143-1150.DOI:10.1016/j.bbrc.2017.08.017.
[9]MARRONE G,SHAH V H,GRACIA-SANCHO J.Sinusoidal communication in liver fibrosis and regeneration[J].J Hepatol,2016,65(3):608-617.DOI:10.1016/j.jhep.2016.04.018.
[10]BALA,CSAK T,SAHA B,et al.The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis[J].J Hepatol,2016,64(6):1378-1387.DOI:10.1016/j.jhep.2016.01.035.
[11]NIELSEN S R,QUARANTA V,LINFORD A,et al.Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis[J].Nat Cell Biol,2016,18(5):549-560.DOI:10.1038/ncb3340.
[12]JIANG S,ZHANG Y,ZHENG J H,et al.Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation[J].Pharmacol Res,2017,117:82-93.DOI:10.1016/j.phrs.2016.11.040.
[13]徐涛,彭云云,李琳,等.pEGFP-C2-NLRC5重组质粒的构建及其表达[J].安徽医科大学学报,2014,49(1):5-8.DOI:10.19405/j.cnki.issn1000-1492.2014.01.002.
XU T,PENG Y Y,LI L,et al.Construction of recombinant plasmid pEGFP-C2-NLRC5 and its expression[J].Acta Universitatis Medicinalis Anhui,2014,49(1):5-8.DOI:10.19405/j.cnki.issn1000-1492.2014.01.002.
[14]李顶春,李武.TGF-β/Smad、MAPK/ERK、NF-κB信号通路对肝纤维化的影响[J].现代免疫学,2017,37(5):427-432.
[15]张望,朱萱.NOX介导的氧化应激对肝纤维化相关信号通路调控的研究进展[J].山东医药,2017,57(9):100-103.DOI:10.3969/j.issn.1002-266X.2017.09.035.
[16]LIU C,YUAN X,TAO L,et al.Xia-Yu-Xue decoction(XYXD) reduces carbon tetrachloride(CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways[J].BMC Complement Altern Med,2015,15:201.DOI:10.1186/s12906-015-0733-1.
[17]CHEN X Q,LIU X,WANG Q X,et al.Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway[J].Exp Cell Res,2015,330(1):43-55.DOI:10.1016/j.yexcr.2014.08.021.
[18]HAN S,DING S,MIAO X,et al.TGF-β1 expression in regulatory NK1.1-CD4+ NKG2D+ T cells dependents on the PI3K-p85α/JNK,NF-κB and STAT3 pathways[J].Am J Cancer Res,2018,8(3):489-501.
[19]DAWOODY NEJAD L,BIGLARI A,ANNESE T,et al.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line[J].Oncol Lett,2017,13(6):4475-4480.DOI:10.3892/ol.2017.5960.